Isolated limb perfusion in the sarcoma-bearing rat: A novel preclinical gene delivery system

Clinical Cancer Research

Volumn 3, Issue 12 I, 1997, Pages 2197-2203

  Milas, Mira ^a   Feig, Barry ^a   Yu, Dihua ^a   Oriuchi, Noboru ^a   Cromeens, Douglas ^a   Ge, Tong ^a   Wong, Franklin C ^a   Kim, E Edmund ^a   Pollock, Raphael ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; CANCER LOCALIZATION; CANCER THERAPY; FEMALE; GENE THERAPY; LIMB PERFUSION; NONHUMAN; PRIORITY JOURNAL; RAT; SARCOMA; SOFT TISSUE SARCOMA; TUMOR GROWTH;

ADENOVIRUSES, HUMAN; ANIMALS; BETA-GALACTOSIDASE; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; FEMALE; FEMORAL ARTERY; FEMORAL VEIN; FIBROSARCOMA; GENE THERAPY; RATS; RATS, INBRED F344; RATS, NUDE; RECOMBINANT PROTEINS; SARCOMA, EXPERIMENTAL; TECHNETIUM; TUMOR CELLS, CULTURED;

EID: 0031427397     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Lienard, D., Ewalenko, P., Delmotte, J. J., Renard, N., and Lejeune, F. J. High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. J. Clin. Oncol., 10: 52-60, 1992.
2. Benckhuysen, C., Van Dijk, W. J., and Van't Hoff, S. C. High-flow isolation perfusion of the rat hind limb in vivo. J. Surg. Oncol., 21: 249-257, 1982.
3. Turner, F. W., Tod, D. M., Francis, G. J., Greenhill, B. J., and Couves, C. M. The technic for isolation-perfusion of the rat hind limb. Cancer Res., 22: 49-52, 1962.
4. Nagel, K., Ghussen, F., Kruger, I., and Isselhard, W. Miniature equipment for the perfusion of rat limbs. Res. Exp. Med., 187: 1-8, 1987.
5. Meyer, T., Gohl, J., Schmidt, O., Spruss, T., Christl C., Bernhardt, G., and Hohenberger, W. Preclinical studies concerning hyperthermic isolated limb perfusion (HILP) of malignant melanoma. Reg. Cancer Treat., 7: 138-143, 1994.
6. Manusama, E. R., Durante, N. M. C., Marquet, R. L., and Eggermont A. M. M. Ischemia promotes the anti-tumor effect of tumor necrosis factor alpha (TNFα) in isolated limb perfusion in the rat. Reg. Cancer Treat., 7: 155-159, 1994.
7. Manusama, E. R., Nooijen, P. T. G. A., Stavast, J., Durante, N. M. C., Marquet, R. L., and Eggermont, A. M. M. Synergistic antitumour effect of recombinant human tumour necrosis factor-α with melphalan in isolated limb perfusion in the rat. Br. J. Surg., 83: 551-555, 1996.
8. Roth, J. A., and Christiano, R. J. Gene therapy for cancer: what have we done and where are we going? J. Natl. Cancer Inst., 89: 21-39, 1997.
9. Lowe, S. W., Bodis, S., McClatchey, A., Remington, L., Ruley, H. E., Fisher, D. E., Houseman, D. E., and Jacks, T. p53 status and the efficiency of cancer therapy in vivo. Science (Washington DC), 266: 807-810, 1994.
10. Ruley, H. E. p53 and response to chemotherapy and radiotherapy. Import. Adv. Oncol., 37-56, 1996.
11. Aas, T., Borresen, A. L., Geisler, S., Smith-Sorensen, B., Johnsen, H., and Varhaug, J. E. Specific p53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients. Nat. Med., 2: 811-814, 1996.
12. Nguyen, D. M., Spitz, F. R., Yen, N., Christiano, R. J., and Roth, J. A. Gene therapy for lung cancer: enhancement of tumor suppression by a combination of sequential systemic cisplatin and adenovirus-mediated p53 gene transfer. J. Thorac. Cardiovasc. Surg., 112: 1372-1376, 1996.
13. Spitz, F. R., Nguyen, D., Skibber, J. M., Meyn, R. E., Christiano, R. J., and Roth, J. A. Adenoviral-mediated wild-type p53 gene expression sensitizes colorectal cancer cells to ionizing radiation. Clin. Cancer Res., 2: 1665-1671, 1996.
14. Grant, J. P., and Wells, S. A. Tumor resistance in rats immunized to fetal tissues. J. Surg. Res., 16: 533-540, 1974.
15. Li, Q., Kay M. A., Finegold, M., Statford-Perricaudet, L. D., and Woo, S. L. Assessment of recombinant adenoviral vectors for hepatic gene therapy. Hum. Gene Ther., 4: 403-409, 1993.
16. Zhang, Y., Yu, D., Xia, W., and Hung, M. C. HER-2/neu-targeting cancer therapy via adenovirus-mediated E1A delivery in an animal model. Oncogene, 10: 1947-1954, 1995.